83 related articles for article (PubMed ID: 23380191)
1. Regulatory space and the contextual mediation of common functional pressures: analyzing the factors that led to the German Efficiency Frontier approach.
Klingler C; Shah SM; Barron AJ; Wright JS
Health Policy; 2013 Mar; 109(3):270-80. PubMed ID: 23380191
[TBL] [Abstract][Full Text] [Related]
2. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
Barron AJ; Klinger C; Shah SM; Wright JS
Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
[TBL] [Abstract][Full Text] [Related]
3. A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden.
Shah SM; Barron A; Klinger C; Wright JS
Health Policy; 2014 May; 116(1):27-36. PubMed ID: 24655685
[TBL] [Abstract][Full Text] [Related]
4. The efficiency frontier approach to economic evaluation: will it help German policy making?
Brouwer WB; Rutten FF
Health Econ; 2010 Oct; 19(10):1128-31. PubMed ID: 20641141
[No Abstract] [Full Text] [Related]
5. Factors that led to the implementation of the efficiency frontier approach to health economic evaluation in Germany: let's talk more about the elephant.
Klingler C; Shah SM; Barron AJ; Wright JS
Health Policy; 2013 Oct; 112(3):299-300. PubMed ID: 24060336
[No Abstract] [Full Text] [Related]
6. Factors that led to the implementation of the efficiency frontier approach in health economic evaluation in Germany: do not avoid the elephant in the room. Comment on Klingler et al. (Health Policy 109 (2013) 270-280).
Sandmann F; Gerber-Grote A; Lhachimi S
Health Policy; 2013 Oct; 112(3):297-8. PubMed ID: 24120262
[No Abstract] [Full Text] [Related]
7. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
8. The efficiency frontier approach to economic evaluation of health-care interventions.
Caro JJ; Nord E; Siebert U; McGuire A; McGregor M; Henry D; de Pouvourville G; Atella V; Kolominsky-Rabas P
Health Econ; 2010 Oct; 19(10):1117-27. PubMed ID: 20575151
[TBL] [Abstract][Full Text] [Related]
9. Historical development of health technology assessment in Thailand.
Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
[TBL] [Abstract][Full Text] [Related]
10. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.
Gagnon MP; Sánchez E; Pons JM
Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192
[TBL] [Abstract][Full Text] [Related]
11. A short history of health technology assessment in Germany.
Perleth M; Gibis B; Göhlen B
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():112-9. PubMed ID: 19500440
[TBL] [Abstract][Full Text] [Related]
12. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
[TBL] [Abstract][Full Text] [Related]
13. Some essential clarifications: IQWiG comments on two critiques of the efficiency frontier approach.
Dintsios CM; Gerber A
Health Econ; 2010 Oct; 19(10):1139-41. PubMed ID: 20842682
[No Abstract] [Full Text] [Related]
14. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
15. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
von der Schulenburg J; Vauth C; Mittendorf T; Greiner W
Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539
[TBL] [Abstract][Full Text] [Related]
16. [More care for a limited budget; a case for a better use of the efficiency criteria].
Rutten FF; Brouwer WB
Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
[TBL] [Abstract][Full Text] [Related]
17. The limited regulatory potential of medical technology assessment.
Elhauge E
Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565
[No Abstract] [Full Text] [Related]
18. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
19. Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment".
Henshall C; Schuller T; Mardhani-Bayne L
Int J Technol Assess Health Care; 2012 Jul; 28(3):203-10. PubMed ID: 22792877
[TBL] [Abstract][Full Text] [Related]
20. A determination of topics for health technology assessment in Thailand: making decision makers involved.
Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
